CatalystWireBeta

Chill Brands Group

CHLL · Main Market · Health Care · mcap £0.9m · 1.7p 2 open situations →

EV
£4.0m
EV / EBIT
–
Net debt
£3.2m
FCF yield
-184.0%
Revenue
£370k
Share price 1y
−85%
Insiders 12m
no deals
Next report
around 29 Jan

Beta Briefing, track record and signals & risks are not ready for Chill Brands Group yet.

We follow 960 UK small caps and every one of their announcements – often hundreds per company. 101 companies are already wired into a briefing: browse them.

Timeline · every situation
dots = announcements

Open · 2

Balance-sheet stress / refinancing

Liquidity and funding constraints

Cash £37,075; reliance on shareholder loan facility

Liquidity has been tight since January 2026, with the company drawing convertible loan and inventory facilities. The interims show cash down to £37,075, a further £540,000 drawn from the largest shareholder's £1.0m facility, finance costs of £273,939 and a £118,947 doubtful-debt provision. The Board calls related-party funding unsustainable and flags tax liabilities as a risk.

Cash
£37,075 at 31 March 2026 (£99,957 at 30 September 2025)
Drawn in period
£540,000 from the largest shareholder's working capital facility of up to £1.0 million
Finance costs
£273,939 (2025: £96,430)
Board view
Reliance on related-party funding is not a sustainable long-term position
Other risk
Historic tax liabilities under ongoing engagement with the tax authority

Next: secure funding or complete a strategic transaction

  1. 30 Jun 2026 Cash £37,075; reliance on shareholder loan facility
  2. 9 Feb 2026 Liquidity flat; drawing convertible loan and inventory facilities
  3. 30 Jan 2026 Tight liquidity; funding requirements acknowledged
Open the full view – chart and every step →
Sale process / strategic review

Corporate and operational structure review

Early-stage talks; no course determined

The structure review began in February 2026 and is now a strategic review of partnerships, investments and transactions. The interims tie it to strengthening the balance sheet and say no course is agreed and no commitments are made. The Board lists execution risk and no certainty of a suitable transaction.

Status
Early-stage discussions; no definitive course of action agreed
Commitments
None entered into
Board ambition
Larger, more diversified public company using the Main Market listing
Aim
Strengthen the balance sheet and enhance shareholder value
Risk
No certainty a suitable transaction will be identified, agreed or completed
Terms
None disclosed

Next: update shareholders on material developments

  1. 30 Jun 2026 Early-stage talks; no course determined
  2. 9 Feb 2026 Review under way
Open the full view – chart and every step →

Company filings. Not investment advice.

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note